Abstract:Nucleotide-binding domain, leucine-rich-repeat-containing family, pyrin domain-containing 3 (NLRP3) is a cytosolic protein that nucleates assembly of inflammasome signaling platforms, which facilitate caspase-1-mediated IL-1β release and other inflammatory responses in myeloid leukocytes. NLRP3 inflammasomes are assembled in response to multiple pathogen- or environmental stress-induced changes in basic cell physiology, including the destabilization of lysosome integrity and activation of K(+)-permeable channels/transporters in the plasma membrane (PM). However, the quantitative relationships between lysosome membrane permeabilization (LMP), induction of increased PM K(+) permeability, and activation of NLRP3 signaling are incompletely characterized. We used Leu-Leu-O-methyl ester (LLME), a soluble lysosomotropic agent, to quantitatively track the kinetics and extent of LMP in relation to NLRP3 inflammasome signaling responses (ASC oligomerization, caspase-1 activation, IL-1β release) and PM cation fluxes in murine bone marrow-derived dendritic cells (BMDCs). Treatment of BMDCs with submillimolar (≤1 mM) LLME induced slower and partial increases in LMP that correlated with robust NLRP3 inflammasome activation and K(+) efflux. In contrast, supramillimolar (≥2 mM) LLME elicited extremely rapid and complete collapse of lysosome integrity that was correlated with suppression of inflammasome signaling. Supramillimolar LLME also induced dominant negative effects on inflammasome activation by the canonical NLRP3 agonist nigericin; this inhibition correlated with an increase in NLRP3 ubiquitination. LMP elicited rapid BMDC death by both inflammasome-dependent pyroptosis and inflammasome-independent necrosis. LMP also triggered Ca(2+) influx, which attenuated LLME-stimulated NLRP3 inflammasome signaling but potentiated LLME-induced necrosis. Taken together, these studies reveal a previously unappreciated signaling network that defines the coupling between LMP, changes in PM cation fluxes, cell death, and NLRP3 inflammasome activation.

Activated MLKL functions as signal II of the NLRP3 inflammasome

Activation of the NLRP1B inflammasome by caspase-8

NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx

Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis

Biological events and molecular signaling following MLKL activation during necroptosis

How location and cellular signaling combine to activate the NLRP3 inflammasome

NLRP3 inflammasome activation and cell death

Necrosome core machinery: MLKL

MLKL post-translational modifications: road signs to infection, inflammation and unknown destinations

The NLRP3 inflammasome: activation and regulation

The intracellular chloride channel proteins CLIC1 and CLIC4 induce IL-1β transcription and activate the NLRP3 inflammasome

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

ZBP1 Drives IAV-Induced NLRP3 Inflammasome Activation and Lytic Cell Death, PANoptosis, Independent of the Necroptosis Executioner MLKL

The NLRP3/ASC/Caspase-1 axis regulates IL-1β processing in neutrophils

Recent Insights into the Regulatory Networks of NLRP3 Inflammasome Activation

The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases

Acylation of MLKL Impacts Its Function in Necroptosis

MLKL Protects Against <i>clostridium Perfringens</i> Infection by Enhancing NLRP3 Inflammasome-Extracellular Traps Axis

NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns

Initiation and perpetuation of NLRP3 inflammasome activation and assembly